
### [MONDO:0016820](http://purl.obolibrary.org/obo/MONDO_0016820)
**Label:** Moyamoya disease

**Subclasses:** [MONDO:0013542](http://purl.obolibrary.org/obo/MONDO_0013542) (Moyamoya disease 5), [MONDO:0012122](http://purl.obolibrary.org/obo/MONDO_0012122) (MYMY3), [MONDO:0014331](http://purl.obolibrary.org/obo/MONDO_0014331) (Moyamoya disease with early-onset achalasia), [MONDO:0011784](http://purl.obolibrary.org/obo/MONDO_0011784) (Moyamoya disease 2), [MONDO:0010448](http://purl.obolibrary.org/obo/MONDO_0010448) (Moyamoya angiopathy-short stature-facial dysmorphism-hypergonadotropic hypogonadism syndrome), [MONDO:0009649](http://purl.obolibrary.org/obo/MONDO_0009649) (MYMY1), 

**Mapped go classes:** [GO:0016887](http://purl.obolibrary.org/obo/GO_0016887) (ATPase activity), [GO:0060047](http://purl.obolibrary.org/obo/GO_0060047) (heart contraction), [GO:0016849](http://purl.obolibrary.org/obo/GO_0016849) (phosphorus-oxygen lyase activity), [GO:0090131](http://purl.obolibrary.org/obo/GO_0090131) (mesenchyme migration), [GO:0002040](http://purl.obolibrary.org/obo/GO_0002040) (sprouting angiogenesis), [GO:0004383](http://purl.obolibrary.org/obo/GO_0004383) (guanylate cyclase activity), [GO:0015629](http://purl.obolibrary.org/obo/GO_0015629) (actin cytoskeleton), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0009190](http://purl.obolibrary.org/obo/GO_0009190) (cyclic nucleotide biosynthetic process), [GO:0035556](http://purl.obolibrary.org/obo/GO_0035556) (intracellular signal transduction), [GO:0030027](http://purl.obolibrary.org/obo/GO_0030027) (lamellipodium), [GO:2000491](http://purl.obolibrary.org/obo/GO_2000491) (positive regulation of hepatic stellate cell activation), [GO:0008074](http://purl.obolibrary.org/obo/GO_0008074) (guanylate cyclase complex, soluble), [GO:0019901](http://purl.obolibrary.org/obo/GO_0019901) (protein kinase binding), [GO:0061041](http://purl.obolibrary.org/obo/GO_0061041) (regulation of wound healing), [GO:2000051](http://purl.obolibrary.org/obo/GO_2000051) (negative regulation of non-canonical Wnt signaling pathway), [GO:0051260](http://purl.obolibrary.org/obo/GO_0051260) (protein homooligomerization), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0014829](http://purl.obolibrary.org/obo/GO_0014829) (vascular smooth muscle contraction), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0044297](http://purl.obolibrary.org/obo/GO_0044297) (cell body), [GO:0030175](http://purl.obolibrary.org/obo/GO_0030175) (filopodium), [GO:0016567](http://purl.obolibrary.org/obo/GO_0016567) (protein ubiquitination), [GO:0061870](http://purl.obolibrary.org/obo/GO_0061870) (positive regulation of hepatic stellate cell migration), [GO:0006182](http://purl.obolibrary.org/obo/GO_0006182) (cGMP biosynthetic process), [GO:0047805](http://purl.obolibrary.org/obo/GO_0047805) (cytidylate cyclase activity), [GO:0016829](http://purl.obolibrary.org/obo/GO_0016829) (lyase activity), [GO:0090594](http://purl.obolibrary.org/obo/GO_0090594) (inflammatory response to wounding), [GO:0061874](http://purl.obolibrary.org/obo/GO_0061874) (positive regulation of hepatic stellate cell contraction), [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0001525](http://purl.obolibrary.org/obo/GO_0001525) (angiogenesis), [GO:0006936](http://purl.obolibrary.org/obo/GO_0006936) (muscle contraction), [GO:0001725](http://purl.obolibrary.org/obo/GO_0001725) (stress fiber), [GO:0030485](http://purl.obolibrary.org/obo/GO_0030485) (smooth muscle contractile fiber), [GO:0051865](http://purl.obolibrary.org/obo/GO_0051865) (protein autoubiquitination), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0008015](http://purl.obolibrary.org/obo/GO_0008015) (blood circulation), [GO:0008217](http://purl.obolibrary.org/obo/GO_0008217) (regulation of blood pressure), [GO:0004016](http://purl.obolibrary.org/obo/GO_0004016) (adenylate cyclase activity), [GO:0006511](http://purl.obolibrary.org/obo/GO_0006511) (ubiquitin-dependent protein catabolic process), [GO:0004842](http://purl.obolibrary.org/obo/GO_0004842) (ubiquitin-protein transferase activity), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0005856](http://purl.obolibrary.org/obo/GO_0005856) (cytoskeleton), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0070374](http://purl.obolibrary.org/obo/GO_0070374) (positive regulation of ERK1 and ERK2 cascade), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), 

**Class expressions from DL-Learner:**

- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 52.94%
- [GO:0030485](http://purl.obolibrary.org/obo/GO_0030485) (smooth muscle contractile fiber) 52.94%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 52.94%
- [GO:0043292](http://purl.obolibrary.org/obo/GO_0043292) (contractile fiber) and [GO:0044449](http://purl.obolibrary.org/obo/GO_0044449) (contractile fiber part) 52.94%
- [GO:0043292](http://purl.obolibrary.org/obo/GO_0043292) (contractile fiber) and [GO:0044422](http://purl.obolibrary.org/obo/GO_0044422) (organelle part) 52.94%
- Thing 52.64%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 38.30%
- [GO:0043292](http://purl.obolibrary.org/obo/GO_0043292) (contractile fiber) 38.30%
- [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 38.30%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0003715](http://purl.obolibrary.org/obo/GO_0003715) (obsolete transcription termination factor activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 38.30%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0003711](http://purl.obolibrary.org/obo/GO_0003711) (obsolete transcription elongation regulator activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 38.30%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0003710](http://purl.obolibrary.org/obo/GO_0003710) (null) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 38.30%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0003709](http://purl.obolibrary.org/obo/GO_0003709) (obsolete RNA polymerase III transcription factor activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 38.30%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0003706](http://purl.obolibrary.org/obo/GO_0003706) (obsolete ligand-regulated transcription factor activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 38.30%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0003704](http://purl.obolibrary.org/obo/GO_0003704) (obsolete specific RNA polymerase II transcription factor activity) or [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component)) 38.30%


